143 related articles for article (PubMed ID: 34394109)
21. Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population-based study.
Xiao Y; Peng S; Hu Y; Zhang J; Cao X
Cancer Med; 2020 Nov; 9(22):8562-8570. PubMed ID: 32941704
[TBL] [Abstract][Full Text] [Related]
22. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
23. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
24. Nomogram based on pre-treatment inflammatory biomarkers predicting survival in patients with head and neck soft tissue sarcoma.
Chen L; Zeng H; Du Z; Zhao Y; Ma X
Cancer Biomark; 2020; 29(1):151-161. PubMed ID: 32623392
[TBL] [Abstract][Full Text] [Related]
25. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
He Z; Deng T; Duan X; Zeng G
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
[TBL] [Abstract][Full Text] [Related]
26. Survival and Prognostic Nomogram for Primary Gastrointestinal Melanoma (PGIM): A Population-based Study.
Badakhshi H; Wang ZM; Li RJ; Ismail M; Kaul D
Anticancer Res; 2021 Feb; 41(2):967-974. PubMed ID: 33517303
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT
J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837
[TBL] [Abstract][Full Text] [Related]
29. Prognostic nomograms based on immune scores for head-neck squamous cell carcinoma patients.
Li W; Zhao K; Wang Z
Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2493-2500. PubMed ID: 33068170
[TBL] [Abstract][Full Text] [Related]
30. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
Wu G; Zhang M
BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
[TBL] [Abstract][Full Text] [Related]
31. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Tian M; Yang J; Han J; He J; Liao W
Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
[TBL] [Abstract][Full Text] [Related]
32. Development and Validation of a Nomogram based on cell growth-related Biomarkers for Oral Squamous Cell Carcinoma.
Shuai Y; Duan Y; Zhou M; Yue K; Liu D; Fang Y; Wang Y; Wu Y; Zhang Z; Wang X
J Cancer; 2021; 12(17):5153-5163. PubMed ID: 34335932
[No Abstract] [Full Text] [Related]
33. Nomogram for predicting overall survival in stage II-III colorectal cancer.
Liu J; Huang X; Yang W; Li C; Li Z; Zhang C; Chen S; Wu G; Xie W; Wei C; Tian C; Huang L; Jeen F; Mo X; Tang W
Cancer Med; 2020 Apr; 9(7):2363-2371. PubMed ID: 32027098
[TBL] [Abstract][Full Text] [Related]
34. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of an immunohistochemical signature in patients with pulmonary squamous cell carcinoma undergoing complete surgical resection.
Lin C; Xi Y; Yu H; Chen X; Shen W
J Thorac Dis; 2022 Feb; 14(2):536-545. PubMed ID: 35280487
[TBL] [Abstract][Full Text] [Related]
36. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy.
Chen J; Zhong W; Yang M; Hou W; Wang X; Xia K; Yu H; Yang M; Zhou B; Wang B; Huang J; Lin T
Cancer Immunol Immunother; 2021 Sep; 70(9):2657-2668. PubMed ID: 33606065
[TBL] [Abstract][Full Text] [Related]
38. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
39. A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma.
Tang X; Pang T; Yan WF; Qian WL; Gong YL; Yang ZG
BMC Cancer; 2020 Nov; 20(1):1095. PubMed ID: 33176731
[TBL] [Abstract][Full Text] [Related]
40. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]